Descemet Endothelial Thickness Comparison Trial II

NCT05275972 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Fuchs
Fuchs Dystrophy
Fuchs' Endothelial Dystrophy

Interventions

DRUG: Ripasudil
DRUG: Placebo

Sponsor

Stanford University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]